|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/506 | |
| A61P 13/02 | |||
| C07D 401/14 |
| (11) | Patento numeris | 3192512 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15839636.6 |
| Europos patento paraiškos padavimo data | 2015-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2015/075567 |
| Data | 2015-09-09 |
| (87) | Numeris | WO 2016/039367 |
| Data | 2016-03-17 |
| (30) | Numeris | Data | Šalis |
| 2014183434 | 2014-09-09 | JP |
| (72) |
MORI, Shinobu, JP
KAJIHARA, Yusuke, JP
INAMURA, Hiroko, JP
HIRATA, Takuya, JP
|
| (73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411,
JP
Cytokinetics, Incorporated, 280 East Grand Avenue, South San Francisco, CA 94080, US |
| (54) | NOVEL PHARMACEUTICAL COMPOSITION FOR URINARY INCONTINENCE PREVENTION AND/OR TREATMENT |
| NOVEL PHARMACEUTICAL COMPOSITION FOR URINARY INCONTINENCE PREVENTION AND/OR TREATMENT |